T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Restaurant Brands International
QSR
$20.9B
| $7.19M | ﹤0.01% |
102,158
-6,706
| -6% | -$472K |
|
1152
Wave Life Sciences
WVE
$1.11B
| $7.18M | ﹤0.01% |
1,439,271
-421,983
| -23% | -$2.11M |
|
|
PARA
1153
DELISTED
Paramount Global Class B
PARA
| $7.18M | ﹤0.01% |
690,547
+20,132
| +3% | +$209K |
|
1154
Applied Industrial Technologies
AIT
$9.92B
| $7.15M | ﹤0.01% |
36,846
+14,239
| +63% | +$2.76M |
|
1155
Royalty Pharma
RPRX
$15.2B
| $7.13M | ﹤0.01% |
270,452
+8,722
| +3% | +$230K |
|
1156
Pacira BioSciences
PCRX
$1.21B
| $7.13M | ﹤0.01% |
249,144
-82,876
| -25% | -$2.37M |
|
1157
Insight Enterprises
NSIT
$3.85B
| $7.11M | ﹤0.01% |
35,848
-373
| -1% | -$74K |
|
1158
Banc of California
BANC
$2.61B
| $7.07M | ﹤0.01% |
553,382
+222,306
| +67% | +$2.84M |
|
1159
Janus Henderson
JHG
$7.02B
| $7.05M | ﹤0.01% |
209,243
+557
| +0.3% | +$18.8K |
|
1160
iShares Russell 1000 Growth ETF
IWF
$122B
| $6.93M | ﹤0.01% |
19,012
-9,465
| -33% | -$3.45M |
|
1161
Alto Neuroscience
ANRO
$102M
| $6.9M | ﹤0.01% |
645,832
+8,228
| +1% | +$88K |
|
1162
Interactive Brokers
IBKR
$27.7B
| $6.82M | ﹤0.01% |
222,396
+9,276
| +4% | +$284K |
|
1163
Agilon Health
AGL
$460M
| $6.81M | ﹤0.01% |
1,040,721
-625,041
| -38% | -$4.09M |
|
1164
AMN Healthcare
AMN
$699M
| $6.8M | ﹤0.01% |
132,609
-283,620
| -68% | -$14.5M |
|
1165
Ovintiv
OVV
$10.5B
| $6.75M | ﹤0.01% |
143,977
-907
| -0.6% | -$42.5K |
|
1166
Wolfspeed
WOLF
$463M
| $6.73M | ﹤0.01% |
295,841
+235,338
| +389% | +$5.36M |
|
|
HCP
1167
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $6.62M | ﹤0.01% |
196,447
-123,232
| -39% | -$4.15M |
|
1168
Neumora Therapeutics
NMRA
$246M
| $6.58M | ﹤0.01% |
669,486
-83,438
| -11% | -$820K |
|
1169
TD Synnex
SNX
$12.6B
| $6.58M | ﹤0.01% |
57,005
+24,245
| +74% | +$2.8M |
|
|
ETRN
1170
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $6.56M | ﹤0.01% |
505,154
+152,161
| +43% | +$1.98M |
|
1171
Brixmor Property Group
BRX
$8.59B
| $6.56M | ﹤0.01% |
283,879
+12,413
| +5% | +$287K |
|
1172
WisdomTree
WT
$2.04B
| $6.54M | ﹤0.01% |
660,069
+31,676
| +5% | +$314K |
|
1173
Timken Company
TKR
$5.39B
| $6.41M | ﹤0.01% |
79,931
-9,386
| -11% | -$752K |
|
1174
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $6.26M | ﹤0.01% |
191,729
+10,448
| +6% | +$341K |
|
1175
Kemper
KMPR
$3.3B
| $6.23M | ﹤0.01% |
105,060
-1,298,444
| -93% | -$77M |
|